INSIGHTS AND PERSPECTIVES

PARIS — A new study indicated that two insulin products made by French drug maker Sanofi lower blood-glucose levels to a greater extent than premixed insulin, and with improvements in quality of life and less hypoglycemia.

Sanofi announced results of the 60-week study, which compared regimens, including Lantus (insulin glargine [rDNA origin]) and Apidra (insulin glulisine [rDNA origin]).

KNOXVILLE, Tenn. — It seems that some Americans look for such claims as "natural," "organic" and "grown in the USA" on food labels.

According to the annual Eco Pulse survey conducted by the Shelton Group — an advertising and research firm that focuses on marketing green products to U.S. shoppers — among 1,013 Americans that were asked what the best description to read on a food label:

• 25% of consumers said they preferred to see "100 percent natural" or "all natural;"

SAN DIEGO — An insulin product made by Eli Lilly appears likely to be more cost-effective than long-acting insulin analog, according to a study presented Friday at the American Diabetes Association’s 71st Scientific Sessions in San Diego.

The company conducted a study comparing the cost-effectiveness of LAIA, insulin lispro mix 75/25 and insulin lispro mix 50/50 in patients with Type 2 diabetes. Lilly sells insulin lispro under the brand name Humalog.

WHAT IT MEANS AND WHY IT’S IMPORTANT — In June 1997, the cover of Wired magazine showed Apple’s logo with a crown of thorns and the foreboding word “Pray.” Amid the nascent tech boom, the company’s stock hit a low of about $12 per share that summer. The future, it seemed, was IBM-compatible.

(THE NEWS: Rite Aid shows off innovation with Wellness store. For the full story, click here.)

SAN DIEGO — Use of a drug for Type 2 diabetes made by Eli Lilly and Amylin Pharmaceuticals may lower patients’ risk of heart failure, according to a new study.

The study of more than 778,000 patients taking the injected drug Byetta (exenatide) found that adding the drug to a pre-existing diabetes regimen, especially if that regimen included insulin, was associated with reduced likelihood of heart failure. Results were presented Saturday at the 71st Scientific Sessions of the American Diabetes Association in San Diego.

NEW YORK — Prices for the top 10 most prescribed branded diabetes drugs have risen faster at Walmart and Kmart than at other retailers, according to a published report.

Citing a recent study by researchers at the Mount Sinai Medical Center in New York, Reuters reported that Walmart raised prices for branded diabetes drugs by 32% between 2008 and 2010, compared with 21% for the industry as a whole — including independent and chain retail pharmacies and mail-order companies. Kmart raised prices by 35%.

WHAT IT MEANS AND WHY IT’S IMPORTANT — Walgreens certainly has the clout to pull off a Mexican standoff with Express Scripts. Some might think all of the tough talk last week is just the kind of posturing one puts on for negotiations and that this will all blow over, similar to last year's standoff between Walgreens and CVS Caremark. So why is it different this time?

(THE NEWS: Walgreens to walk away from Express Scripts in 2012. For the full story, click here.)

SAN DIEGO — Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

The drug maker found that combining Victoza (liraglutide [rDNA origin] injection) with metformin and/or sulfonylurea helped patients achieve blood-sugar control.